Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  News  >  Companies

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Former Schneider Electric Executive and Blackberry-Cylance President Daniel Doimo Joins WhiteFox Board of Directors

share with twitter share with LinkedIn share with facebook
09/25/2020 | 05:01pm EDT

SAN LUIS OBISPO, Calif., Sept. 25, 2020 /PRNewswire/ -- WhiteFox, a global leader in drone airspace security, announced today that Daniel Doimo, a former President at Blackberry/Cylance and President and COO of Cylance, an AI cybersecurity unicorn, will be joining the Board of Directors.

Daniel is a highly experienced global business executive. He has successfully led teams in Europe, Asia, and the United States both in start-ups and large global organizations. His experience spans numerous technologies to include Power Systems, Data Centers, IoT, Energy Management, Software, Cybersecurity, and Artificial Intelligence.

As Cylance's President and COO, he led the AI-focused startup's growth until Cylance was acquired by Blackberry in 2019. Daniel remains active in an advisory capacity.

Prior to joining Cylance, Daniel served as the Executive Vice President of Global Solutions and a member of the Executive Committee at Schneider Electric. During his 12 years at Schneider, he was instrumental in the merger of MGE UPS Systems with APC, and then led the Power Business Unit, the IT business, and finally Global Solution, a division regrouping Services, Software, and Strategic End-User Segments.

Daniel is bilingual in English and French and proficient in other languages, he holds an MBA from Pepperdine University.

Luke Fox, Founder and CEO of WhiteFox, shared, "Daniel is a proven leader with extensive experience in cybersecurity, strategic partnerships, and board governance. We are confident that Daniel will add significant value both as an entrepreneur and advisor as WhiteFox continues to grow its impact worldwide."

"We are honored and excited to have a leader of Daniel's caliber and security expertise join the WhiteFox board. Daniel's deep industry network and strategic guidance will further enable WhiteFox to bring their world-class counter drone technology into the hands of governments, critical infrastructure, and corporations that seek to protect their airspace from unauthorized drones," stated Jeff Bocan, WhiteFox Board Director and Partner at Okapi Venture Capital.

Daniel Doimo shared, "WhiteFox has championed some of the most important initiatives shaping the future of airspace security. I'm very eager to work with such an enthusiastic and esteemed team to continue WhiteFox's mission of safely integrating drones into our lives."

About WhiteFox: Headquartered in California, WhiteFox's mission is to keep the sky open for responsible pilots by creating solutions that advance drone technology for a better world. As a global leader in pioneering the safe integration of drones into society and offering worldwide drone airspace security solutions, WhiteFox is securing trusted autonomy through transparency and accountability in our skies. Find them on Facebook, Instagram, Twitter, and LinkedIn.

Contact: Bobby Sakaki
Phone: (805) 250-9690
Email: press@whitefoxdefense.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/former-schneider-electric-executive-and-blackberrycylance-president-daniel-doimo-joins-whitefox-board-of-directors-301138407.html

SOURCE WhiteFox Defense

© PRNewswire 2020

share with twitter share with LinkedIn share with facebook
Latest news "Companies"
11:41aEXCLUSIVE : Leading investors in Ant Shanghai IPO submit bids in 68-69 yuan/share range, say sources
11:31aSPOT COFFEE CANADA : Comments on Reinstatement Review
11:07aORGANOCLICK : winner of Clean Equity Monaco Award given out by H.S.E Prince Albert II of Monaco
10:55aVEDANTA : Intimation for declaration of first Interim Dividend for FY 2020-21
10:40aREVOLUTION MEDICINES : Intermittent dosing of RMC-4630, a potent, selective inhibitor of SHP2, combined with the MEK inhibitor cobimetinib, in a phase 1b/2 clinical trial for advanced solid tumors with activating mutations of RAS signaling
10:16aTURNING POINT THERAPEUTICS : Presents Initial Clinical Data From Phase 1 SHIELD-1 Study of Novel MET/SRC/CSF1R Inhibitor TPX-0022 at 2020 EORTC-NCI-AACR Symposium
10:16aTurning Point Therapeutics Presents Initial Clinical Data From Phase 1 SHIELD-1 Study of Novel MET/SRC/CSF1R Inhibitor TPX-0022 at 2020 EORTC-NCI-AACR Symposium
10:00aFINAL DEADLINE ALERT : ROSEN, A LEADING AND RANKED FIRM, Reminds Progenity, Inc. Investors of Important October 27 Deadline in Securities Class Action – PROG
09:46a(GOCO) ALERT : GoHealth Investors Reminded of Class Action Deadline; Investors with Losses Over $100,000 Encouraged to Contact Firm - Johnson Fistel, LLP
Latest news "Companies"